Delivery Order SPE2DX22D0079-SPE2D826FAAN1

The U.S. Defense Logistics Agency Medical Supply Chain has awarded a delivery order valued at $50,945.95 to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3), a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania. This competitive, non-set-aside contract was issued on November 10, 2025, with an ultimate completion date of November 12, 2025, and operates under firm fixed pricing terms. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a ceiling value of $999,999,999.00 and extends through December 2026.

AmerisourceBergen's pharmaceutical supply portfolio under the DLA Medical Supply Chain vehicle encompasses a comprehensive range of medical commodities, including brand-name and generic medications, specialty pharmaceuticals for diabetes and neurological conditions, vaccines, antibiotics, pain management products, and specialized medical supplies such as auto-injectors and test kits. The company serves critical healthcare needs across military and federal systems, including the Defense Health Agency and U.S. Coast Guard. This delivery order continues AmerisourceBergen's established role as a prime vendor in the DLA's global pharmaceutical support operations, with the company positioned among multiple contractors expected to support the agency's upcoming Pharmaceutical Prime Vendor Global Program Generation V regional contracts.